← All claims

Diets

ketogenic diet does-not-improve systolic blood pressure more than other diets

In plain terms: Is the ketogenic diet the best diet for lowering blood pressure?

Leans support Diets 🔬 Includes disconfirming

Part of: 🥗 ketogenic diet

RefutedContestedStrong support
consensus score 0.30

No — any BP reduction is modest and mostly from weight loss; DASH and intermittent fasting outperform keto for lowering blood pressure.

📅 Last reviewed: 2026-07-15

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

6 support 4 contradict 1 tested null 3 mixed · 14 sources, 10 independent groups

The evidence (14)

SourceGradeStanceQualityFinding
Zhao
2026 · Front Nutr
meta-analysis tested-null low Meta-analysis shows DASH significantly improves metabolic-syndrome components including blood pressure, reinforcing DASH over keto.
Pescari D et al
2025 · Nutrients
observational contradicts low Non-randomized 12-wk clinic comparison, n=49 adults with obesity: modified KD (n=23, carb <=50 g/d, isocaloric) vs TRE (n=26, 4-10 h window, ad libitum); allocation by voluntary presentation and 'mutual agreement', per-protocol only. Median SBP reduction 8.97% (IQR 3.41, 12.50) on KD vs 1.42% (IQR 0, 2.94) on TRE, between-group Mann-Whitney p<0.001 (Table 3; U=85.0, rank-biserial 0.716, post hoc power only 0.660). Baseline SBP did not differ (122 vs 126 mmHg, p=0.790), but the KD arm started heavier and lost ~3x more weight (BMI -12.71% vs -4.06%), so the SBP gap is confounded with weight loss, not attributable to macronutrient pattern. Internally inconsistent: the Discussion states 'systolic blood pressure, p = 0.10' and that the between-group difference 'did not reach conventional levels of statistical significance', a figure that appears in no table; the Conclusion declines to claim superiority. LDL-C and triglycerides are tabulated at baseline but omitted from the change analysis.
Bensaaud
2025 · Cochrane Database Syst Rev
meta-analysis supports high Cochrane review confirms DASH lowers blood pressure, establishing a non-keto diet as the evidence-based BP-lowering pattern.
Wang
2024 · Am J Clin Nutr
meta-analysis mixed high Meta-analysis of RCTs found ketogenic diets did not significantly lower systolic or diastolic blood pressure versus control.
Schiavo
2022 · Obes Surg
RCT mixed low Low-calorie ketogenic diet did lower systolic/diastolic BP but via weight loss combined with CPAP, not a keto-specific antihypertensive effect.
Amini
2024 · Nutr Metab Cardiovasc Dis
meta-analysis contradicts moderate GRADE-assessed meta-analysis of RCTs found the ketogenic diet produced no significant effect on systolic or diastolic blood pressure.
Gomez-Perez
2025 · Eur J Prev Cardiol
RCT mixed moderate Sub-analysis of an RCT using 24-h ambulatory BP found ketogenic potential of the diet was not the key driver of BP change among hypocaloric interventions.
Lv J, Jiao S, Li W, Ding S, Ma L, Zhang Q
2025 · Front Nutr
meta-analysis contradicts low Network meta-analysis of 26 RCTs / 2,255 MetS patients comparing six dietary patterns plus control. On SBP the KETOGENIC diet ranked FIRST: 'The results of SUCRA ranking were as follows: the ketogenic diet (SUCRA = 95.8%) > DASH diet (SUCRA = 70.8%) > low-carbohydrate diet (SUCRA = 61.2%) > low-fat diet (SUCRA = 56.9%) > Mediterranean diet (SUCRA = 43.6%) > control diet (SUCRA = 17.2%) > vegan diet (SUCRA = 4.4%).' Keto vs control MD = -11.00 (-17.56, -4.44) vs DASH's -5.99 (-10.32, -1.65); keto significantly beat vegan (13.38; 5.25, 21.52) and Mediterranean (8.13; 0.22, 16.04). Authors' own summary: 'With regard to lowering blood pressure and triglyceride levels, the ketogenic diet proved to be the most effective.' WHAT THE HEADLINE n DOES NOT COVER: the ketogenic node for blood pressure rests on ONE trial. Two keto RCTs were included - Volek 2009 (20 vs 20, 12 wk, keto vs low-fat) and Pinsawas 2017 (26 vs 22, 52 wk, keto vs typical Thai control) - and the blood-pressure article list ('Eighteen articles ( 22 , 24 - 28 , 32 , 34 - 37 , 39 - 41 , 43 , 45 - 47 ) reported on blood pressure') excludes Volek (ref 31). So 48 randomised participants in a single Thai trial carry the entire keto BP node, and every keto-vs-other-diet contrast above is INDIRECT via the control node. Keto was NOT significantly better than DASH (5.01; -2.85, 12.87), low-carbohydrate (6.46; -2.33, 15.25) or low-fat (6.89; -0.90, 14.68). Reliability caveats the authors state themselves: 'There remained a possibility of publication bias within the research network'; control diets were heterogeneous and poorly specified; 'Among the 26 studies reviewed, 14 used an energy-restricted design, 8 studies were non-energy-restricted, and 4 studies did not report whether they were energy-restricted', so energy restriction confounds the diet contrast; 5 of 26 trials were at high risk of bias; no GRADE or CINeMA certainty rating is reported. Pinsawas is 52 weeks and therefore falls outside the 12-48-week sensitivity window; what became of the keto BP estimate there is cannot-tell from the available text (Supplementary File 2 is not in the drop).
Kazeminasab
2025 · Eur J Clin Nutr
meta-analysis contradicts moderate Hypocaloric low-carb diets did not change blood pressure versus low-fat diets, and very-low-carb reduced flow-mediated dilation.
Ge
2020 · BMJ
meta-analysis supports high Network meta-analysis of 14 named diets found blood-pressure advantages largely disappeared by 12 months, with no keto superiority.
⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction
Sun
2025 · Sci Rep
meta-analysis supports moderate Network meta-analysis of 21 RCTs: DASH and intermittent fasting best lowered systolic BP, with the ketogenic diet not ranking as a top blood-pressure intervention.
Arnotti
2022 · Clin Nutr
meta-analysis supports moderate Increased fruit/vegetable intake lowered blood pressure in overweight/obese adults, supporting plant-forward over keto for BP.
Du Y et al
2025 · study_type: RCT
RCT supports low Keto vs low-fat diet RCT, n=60: 'no significant differences in clinical or metabolic outcomes between groups' except ketone levels; keto-arm SBP within-group 131.2->123.1 (p=0.006) but not a between-group comparison
Aljuraiban
2024 · Adv Nutr
meta-analysis supports moderate Umbrella review of 341 meta-analyses identifies DASH and Mediterranean patterns (not keto) as recommended for hypertension.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.